the present invention relates to bisarylimidazolyl derivatives and pharmaceutical compositions comprising said compounds inhibiting fatty acid amide hydrolase and useful for the treatment of pain , particularly neuropathic pain , psychomotor disorder , hypertension , cardiovascular disease , eating disorder , nausea , aids - related complex , glaucoma , inflammation , psoriasis or multiple sclerosis , and other conditions the treatment of which can be effected by inhibiting fatty acid amide hydrolase .